Curaleaf Holdings Inc. (CURA.TO) — Quality & forensics
As of 2026-10-15 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 24
- Quality 23
- Growth 38
- Balance sheet 24
- Cash quality 35
- Capital allocation 17
- Momentum 42
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the distress zone (below 1.81). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the CURA.TO chart & overview
FAQ · from the current data · as of 2026-10-15
Quick answers
What is Curaleaf Holdings Inc.'s Closelooknet quality reading?
The composite reads 29/100 across 7 modules, as of 2026-10-15: valuation 24, quality 23, growth 38, balance sheet 24, cash quality 35, capital allocation 17, momentum 42. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Curaleaf Holdings Inc.'s Altman Z-Score?
0.76, which sits in the distress zone (below 1.81) as of 2026-10-15. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Curaleaf Holdings Inc.'s Piotroski F-Score?
3 of 9, as of 2026-10-15. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Curaleaf Holdings Inc.'s Beneish M-Score indicate?
-2.77 — below the −1.78 manipulation-risk threshold, as of 2026-10-15. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- LNTH Lantheus Holdings Incindustry
- BHC.TO Bausch Health Companies Incindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- GALDY GALDERMA GROUP AGindustry
- FAGR.BR Fagron NVindustry
- PRGO Perrigo Company PLCindustry
- HCM.L HUTCHMED China Ltdindustry
- VTRS Viatris Incindustry
- UTHR United Therapeutics Corporationindustry
- AMRX Amneal Pharmaceuticals, Inc. Class A Common Stockindustry
- ZTS Zoetis Incindustry
- ELAN Elanco Animal Healthindustry
- DMP.DE Dermapharm Holding SEindustry
- ALM.MC Almirall S.A.industry
- NBIX Neurocrine Biosciences Incindustry
- APTX.TO Apotex Health Corpindustry
- HALO Halozyme Therapeutics Incsector
- DXCM DexCom Incsector
- ARGX.BR Argen-Xsector